Skin color is a major area of study in dermatology, and more broadly, renewed emphasis has recently been placed on identifying disparities in accuracy of clinical technologies such as pulse oximeters among patients with different skin tones.1–4 Pigmentation elements, such as melanin, hemoglobin, and carotenoids, selectively absorb light at specific wavelengths; the remainder of the light can be scattered back to the surface to be detected by the eye as a “skin color.” This detected “color” is a combination of the spectrum of the incident light, the specular and diffuse reflectance of the tissue, and the spectral response of the eye. Colorimetric measurements of the skin, which rely on diffusely backscattered light, can provide information about the relative amounts of these absorbing components in the skin. The use of skin colorimetry has been common for the past 50 years to characterize reactivity of normal skin to light (e.g., tanning and erythema) and to diagnose and monitor conditions, such as port-wine stain and skin cancer.2